Oncimmune distributor gets approval for 'EarlyCDT-Lung' in Israel

15th May 2019 15:27

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Wednesday that its distributor for Israel, Best Medical Opinion, has received regulatory approval for the sale of the 'EarlyCDT-Lung' product in Israel.The AIM-traded firm said that an age standardised basis, Israel's lung cancer mortality rate was 18.2 per 100,000 persons, making it one of the highest rates in the Middle East region.Lung cancer was responsible for more cancer-related deaths than any other cancer in the country."We welcome this latest approval which paves the way for the near-term commencement of commercial sales in the sophisticated healthcare market of Israel," said chief executive officer Dr Adam Hill.

Top Risers

Share	Price	Change
Riverfort (RGO)	0.35	59.09%
Harvest Mi (di) (HMI)	0.30	20%
Empyrean (EME)	0.105	16.67%
Sosandar (SOS)	7.25	16%
Cropper (J) (CRPR)	180.00	14.29%

Top Fallers

Share	Price	Change
Belluscura (BELL)	0.55	-18.52%
Pri0r1ty Int (PR1)	2.875	-17.86%
Wishbone (WSBN)	0.19	-17.39%
Mirriad Advertising (MIRI)	0.0275	-16.92%
Fulcrum Metals (FMET)	4.75	-15.79%

Top By Volume

Share	Price	Volume
Mosman Oil & Gas (MSMN)	0.0655	1,237,511,352
Caledonian Hold (CHP)	0.00375	986,303,446
Premier African Minerals (PREM)	0.029	736,738,600
Sunda Energy (SNDA)	0.0475	516,412,006
Empyrean (EME)	0.105	415,952,903

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.